comprehensive -WSS

comprehensive

author：focus 2025-09-30 14:53:32 - browse：79371

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

WSS

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Ahead of JPM, here's who's profiting most in health care

The FDA must approve intranasal treatments for anaphylaxis

Breakthrough Alzheimer’s drugs are inaccessible in rural states

The FDA must approve intranasal treatments for anaphylaxis

5 important ways Henrietta Lacks changed medical science

focus

comprehensive

hotspot

What does generative AI mean for health care? We asked experts

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Heart attack and stroke risk calculators need revising

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Heart attack and stroke risk calculators need revising

Goldman Sachs launches $650M fund for life science investments

New air purifier tech could be key to improving indoor air quality

Morgan Health, with ambitious aims, wants you to know it’s still here

Malaria cases in Florida and Texas: Here’s what you need to know

Mega Millions pot grows to $1.25 billion after no winner

hotspot

GSK Flovent asthma inhalers replaced by authorized generics

5 important ways Henrietta Lacks changed medical science

Physician groups backed by private equity giant lobby on mergers

White House finalizes ITC's import ban of latest Apple Watches

Feng Zhang CRISPR delivery startup lays off quarter of staff

EQRx, failed developer of low

focus

focus

entertainment

focus